Gastric cancer (GC) is one of the most clinically challenging cancers worldwide. Over the
past few years, new molecular-targeted agents and immunotherapy have markedly …

DNA replication is the fundamental process for accurate duplication and transfer of genetic
information. Its fidelity is under constant stress from endogenous and exogenous factors …

Yes‐associated protein (YAP) is a transcriptional coactivator that promotes cell proliferation,
stem cell maintenance and tissue homeostasis. The YAP activity is primarily regulated …

LINC‐PINT is a p53‐induced long intergenic noncoding transcript that plays a crucial role in
many diseases, especially cancer. This long noncoding RNA (lncRNA) gene produces in …

Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) is a specific transcription factor with
potent effects on the regulation of antioxidant gene expression that modulates cell …

Gastric cancer is a common oncological disease. Although enormous efforts have been
expended, possible therapeutic modalities are still limited. For this reason, new therapeutic …

To better treat gastric diseases and lower systemic side effect, it is essential to design new
vectors to control drug release in stomach. Aiming to this challenge, we developed a new …

Background High‐quality randomized controlled trials have demonstrated the benefit of
radiotherapy (RT) in patients with radical resected gastric cancer (GC), however, utilization …

Stomach cancer is an aggressive disease and represents a global health problem. The
majority of patients with localised disease present with locally advanced cancer that requires …

Gastric cancer is a common digestive tract malignancy that is mainly treated with surgery
combined with perioperative adjuvant chemoradiotherapy and biological targeted therapy …